Aneurysmal Subarachnoid Hemorrhage

<p>Aneurysmal Subarachnoid Hemorrhage</p> <p>Special Guest: Casey May, PharmD, BCCCP</p> <p> </p> <p>Show Notes: <a href='https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf'>https://pharmacytodose.files.wordpress.com/2020/06/asah-show-notes.pdf</a></p> <p> </p> <p>Reference List: <a href='https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf'>https://pharmacytodose.files.wordpress.com/2020/06/asah-references.pdf</a></p> <p> </p> <p>02:51 – Types of intracerebral bleeds; 06:19 – Types of subarachnoid hemorrhage; 08:25 – Pathophysiology of aSAH; 10:45 – Risk factors; 12:48 – Classic aSAH presentation; 16:36 – Classificiation systems; 22:25 – Prioritizating acute management of aSAH; 25:15 – Blood pressure goals; 26:21 – Preferred anti-HTN agent?; 28:25 – Biggest concerns with anti-HTN agents; 31:08 – ICP management; 35:40 – Surgical clipping v. Endovascular coiling; 42:51 – Cerebral vasospasms and delayed cerebral ischemia; 55:07 – Nimodipine in aSAH; 68:20 – DVT prophylaxis; 73:48 – Seizure prophylaxis; 76:30 – Augmented renal clearance; 83:56 – Take-home points</p> <p>  </p> <p>PharmacyToDose.Com</p> <p>@PharmacyToDose on Twitter/Instagram</p> <p><a href='mailto:PharmacyToDose@Gmail.com'>PharmacyToDose@Gmail.com</a></p>